Skip to main content

LinkedIn
Instagram
Facebook
YouTube
Email

People
Events
News

Search site:

National Cancer Institute

Frederick National Laboratory

Menu

Mega Menu

Research & Technology
- Science Areas
  - AIDS and Cancer Virus Program
  - Basic Science Program
  - Bioinformatics and Computational Science
  - Cancer Research Technology Program
  - Laboratory Animal Sciences Program
  - Vaccine, Immunity, and Cancer Directorate
  HIV/SIV research
  Researchers identify lower GI tract tissues as source of initial rebound of HIV-like virus after stopping ART
  A new study used an innovative method to track anatomic origin of rebound of HIV-like virus.
- Clinical Trial Support
  - Applied and Developmental Research Directorate
  - Biopharmaceutical Development Program
  - Clinical Monitoring Research Program
  - Clinical Research Directorate
  - Vaccine Clinical Materials Program
  Analysis of paired blood biopsies, tumor tissue as biomarkers for cancer to be presented at ASCO
  FNL scientists will present a recent study comparing mutations found in paired tuors and ctDNA at the 2026 American Society for Clinical Oncology Annual Meeting.
- Publications
NIH partnership establishes new Gene Therapy Immunology and Standards Laboratory
A new initiative aims to standardize gene therapy research, speeding the path to clinical trials and new treatments.
Innovation & Initiatives
- Initiatives
  - RAS Initiative
  - Scientific Standards Hub
  Save the date Oct 7-9, 2026
  
  6th RAS Initiative Symposium
  Join us for the 2026 RAS Initiative Symposium.
- Innovation
  - Center for Innovation and Strategic Partnerships
  - Patents
  Importance of innovation Within FNL, innovation plays a pivotal role in delivering new and enhanced technologies that empower us to tackle essential scientific inquiries, enhance our services, and ultimately contribute to the wellbeing of patients.
  Vladimir Popov, Ph.D., MBA
- Scientific Series
  Sep 9, 2026
  
  2026 Technology Showcase
  Free, in-person event with networking and one-on-one partnering opportunities.
American Association for Cancer Research Annual Meeting
Preclinical data on potential treatment for RAS-driven cancers to be presented at AACR26
Studies on BBO-10203 and BBO-11818 will be presented in San Diego.
Investigator Resources
Training
FNL Global Clinical Research Educational Modules
Learn about challenges in clinical research during emergency infectious disease outbreaks and strategies to overcome them.
Work With Us
Vendor Webinar Sep 24, 2026

Q3 How to Do Business with Leidos Biomedical Research
This session will provide a roadmap for navigating the procurement process.
Careers
Brilliant teamwork The team here is made up of brilliant scientists. Coming from a diverse research background myself, it’s inspiring to be in a room where everyone contributes something unique. I feel truly privileged to be part of it.
Samarth Mathur, Ph.D.
About FNL
Did you know?

In the 10-year period 2012-2022, the Vaccine Clinical Materials Program completed 300+ shipments supporting approximately 100 clinical trials across 45 products.

Publications

Body

Below you'll find a list of all our scientific publications.

Only authors from the Frederick National Laboratory for Cancer Research are displayed.

Search

Search by title, keyword, or author. Use the filters to narrow results by specific programs and laboratories.

Search

[Apply]

Filters

Publication Date

Min

Max

Directorate / Lab / Affiliation

AIDS Monitoring Laboratory

AIDS and Cancer Virus Program

Advanced Biomedical Computational Science

Advanced Cryo-Electron Microscopy Technology Group

Animal Diagnostics Laboratory

Animal Research Technical Support

Antibody Characterization Laboratory

Applied and Developmental Research Directorate

Basic Science Program

Bioinformatics and Computational Science

Biological Products Core

Biopharmaceutical Development Program

Biophysics and Computational Biology Section

Bioprocessing Laboratory

Biospecimen Research Group

Blood Processing Core

Cancer Genomics Research Laboratory

Cancer Imaging Informatics Laboratory

Cancer Immunoprevention Laboratory

Cancer Research Technology Program

Cellular Immunity Core

Center for Technical Operations Support

Clinical Monitoring Research Program

Clinical Support Laboratory

Contracts and Acquisitions

Drug Discovery and Development Program

Epigenetics Section

Flow Cytometry Support Laboratory

Genome Modification Core

Gnotobiotics Facility

HIV Molecular Monitoring Core

HLA Immunogenetics Section

HPV Serology Laboratory

Imaging Mass Cytometry Laboratory

Immunological Monitoring Laboratory

In Vitro Evaluation and Molecular Pharmacology Laboratories

In Vivo Evaluation Program

Investigative Toxicology Laboratory

Laboratory Animal Medicine

Laboratory Animal Sciences Program

Laboratory of Human Retrovirology and Immunoinformatics

Laboratory of Molecular Cell Biology

Molecular Histopathology Laboratory

Molecular Immunology Section

Molecular Pharmacology Program

Mouse Modeling and Cryopreservation

Nanotechnology Characterization Laboratory

National Cryo-Electron Microscopy Facility

Natural Products Support Group

Neutrophil Monitoring Laboratory

Nonhuman Primate Research Support Core

Pharmacokinetics and Drug Analysis Group

Protein Expression Laboratory

Quantitative Molecular Diagnostics Core

Radiochemistry Program

Radiochemistry Support Group

Retroviral Evolution Section

Retroviral Pathogenesis Section

Retrovirus-Cell Interaction Section

Small Animal Imaging Program

Tissue Analysis and Retroviral Protein Chemistry Core

Vaccine Clinical Materials Program

Vaccine, Immunity, and Cancer Directorate

Viral Evolution Core

Viral Oncology Section

Viral Persistence Section

Virus Isolation and Serology Laboratory

Apr1

2026

Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaques

Sci Transl Med

PMID 42054491

Fennessey CM, Keele BF, and 31 more

AIDS and Cancer Virus Program › Retroviral Evolution Section, Viral Evolution Core

Apr1

2026

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update

J Clin Oncol

PMID 41999612

Ferry-Galow KV, Fino KK, Miller BL, Wilsker DF, Begum A, Parchment RE, and 22 more

Applied and Developmental Research Directorate

Apr1

2026

Bacterial dysbiosis, cervico-vaginal Human Papillomaviruses and inflammation persist in Ugandan women living with HIV after a year of antiretroviral treatment

J Infect Dis

PMID 41999406

Callier V, and 15 more

Clinical Monitoring Research Program

Apr1

2026

CRISPR-based gene dependency screens reveal mechanism of BRAF inhibitor resistance in anaplastic thyroid cancer

Mol Carcinog

PMID 42035477

Sun D, Lobanov A, Andresson T, Chan K, O'Neill M, Chari R, and 21 more

Bioinformatics and Computational Science › Advanced Biomedical Computational Science, Laboratory Animal Sciences Program › Genome Modification Core, Cancer Research Technology Program

Apr1

2026

Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS (G12C) suppresses PI3Kα and leads to potent tumor inhibition

biorXiv

PMID 42094443

Maciag AE, and 25 more

Cancer Research Technology Program

Apr1

2026

Durable protection against SIV challenge by adeno-associated virus delivery of Env-specific antibodies

bioRxiv (Preprint)

PMID 42079130

Fennessey CM, Keele BF, and 16 more

AIDS and Cancer Virus Program › Retroviral Evolution Section, Viral Evolution Core

Apr1

2026

Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1

J Neuroendocrinol

PMID 41883001

Kozlov SV, Guerin TM, Custer Lawrence W, Bassel LL, and 6 more

Laboratory Animal Sciences Program › Molecular Histopathology Laboratory

Apr1

2026

Energy landscapes in molecular biology: history, principles, and perspectives

Q Rev Biophys

PMID 42015616

Nussinov R, Jang H, and 1 more

Basic Science Program

Apr1

2026

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial

Clin Infect Dis

PMID 42017206

Schechner AJ, and 53 more

Clinical Monitoring Research Program

Apr1

2026

Free energy and flexibility analysis of autoinhibited human BRAF

J Chem Inf Model

PMID 42013449

Nissely DV, and 11 more

Cancer Research Technology Program

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Frederick National Laboratory for Cancer Research is operated by Leidos Biomedical Research, Inc. for the National Cancer Institute.

LinkedIn
Instagram
Facebook
YouTube
Email

Quick Links

Contact Us
Accessibility
Conflict of Interest
Privacy Policy
HHS Vulnerability Disclosure

National Cancer Institute

U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov

Research & Technology
Innovation & Initiatives
Investigator Resources
- All Resources
- Data & Repositories
- National Scientific User Facilities
  - Nanotechnology Characterization Laboratory
  - National Cryo-Electron Microscopy Facility
- Training & Education
- Technical Services
- Universal Standards & Reference Materials
Work With Us
Careers
About